Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pulmonx (LUNG) Receivables - Net (2019 - 2025)

Pulmonx (LUNG) has disclosed Receivables - Net for 7 consecutive years, with $13.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Net rose 18.23% to $13.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $13.8 million, a 18.23% increase, with the full-year FY2024 number at $13.1 million, up 8.38% from a year prior.
  • Receivables - Net was $13.8 million for Q3 2025 at Pulmonx, down from $15.9 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $15.9 million in Q2 2025 to a low of $5.1 million in Q1 2021.
  • A 5-year average of $9.7 million and a median of $8.9 million in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: soared 55.2% in 2021, then grew 4.36% in 2022.
  • Pulmonx's Receivables - Net stood at $6.6 million in 2021, then soared by 32.23% to $8.7 million in 2022, then skyrocketed by 39.51% to $12.1 million in 2023, then rose by 8.38% to $13.1 million in 2024, then rose by 5.16% to $13.8 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Receivables - Net are $13.8 million (Q3 2025), $15.9 million (Q2 2025), and $14.0 million (Q1 2025).